| Acute Exacerbations of COPD: Identification of Biological Clusters and Their Biomarkers. | |
| | |
MedLine Citation:
|
PMID: 21680942 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Rationale Exacerbations of chronic obstructive pulmonary disease (COPD) are heterogeneous with respect to inflammation and etiology. Objectives Investigate biomarker expression in COPD exacerbations to identify biological clusters and determine biomarkers that recognise clinical COPD exacerbation phenotypes namely those associated with bacteria, viruses or eosinophilic airway inflammation. Methods Patients with COPD were observed for 1 year at stable and exacerbation visits. Biomarkers were measured in sputum and serum. Viruses and selected bacteria were assessed in sputum by polymerase chain reaction and routine diagnostic bacterial culture. Biological phenotypes were explored using unbiased cluster analysis and biomarkers that differentiated clinical exacerbation phenotypes were investigated. Measurements and Main Results 145 patients (101 men, 44 women) entered the study. 182 exacerbations were captured from 86 patients. Four distinct biological exacerbation clusters were identified. These were bacterial, viral or eosinophilic-predominant and a fourth was associated with limited changes in the inflammatory profile and was termed pauci-inflammatory. Of all exacerbations, 55%, 29% and 28% were associated with bacteria, virus and/or a sputum eosinophilia. The biomarkers that best identified these clinical phenotypes were sputum IL-1β (area under receiver-operator-characteristic-curve 0.89 (95% confidence interval 0.83 to 0.95), serum CXCL10 0.83 (0.70 to 0.96), and percentage peripheral eosinophils 0.85 (0.78 to 0.93) respectively. Conclusion The heterogeneity of the biological response of COPD exacerbations can be defined. Sputum IL-1β, serum CXCL10 and peripheral eosinophils are biomarkers of bacteria, virus or eosinophil associated exacerbations of COPD. Whether phenotype-specific biomarkers can be applied to direct therapy warrants further investigation. |
| | |
Authors:
|
Mona Bafadhel; Susan McKenna; Sarah Terry; Vijay Mistry; Carlene Reid; Pranabashis Haldar; Margaret McCormick; Koirobi Haldar; Tatiana Kebadze; Annelyse Duvoix; Kerstin Lindblad; Hemu Patel; Paul Rugman; Paul Dodson; Martin Jenkins; Michael Saunders; Paul Newbold; Ruth H Green; Per Venge; David A Lomas; Michael R Barer; Sebastian L Johnston; Ian D Pavord; Christopher E Brightling |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-6-16 |
Journal Detail:
|
Title: American journal of respiratory and critical care medicine Volume: - ISSN: 1535-4970 ISO Abbreviation: - Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-6-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9421642 Medline TA: Am J Respir Crit Care Med Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Institute for Lung Health, University of Leicester, Leicester, United Kingdom; Department of Infection, Immunity & Inflammation, University of Leicester, Leicester, United Kingdom. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Encouraging Consumption of Water in School and Child Care Settings: Access, Challenges, and Strategi...
Next Document: Effect of 5 Genetic Variants Associated with Lung Function on the Risk of COPD, and their Joint Effe...